THURSDAY, Oct. 12, 2023 (HealthDay News) — Severe inflammation very early in childhood might hamper the development of key brain cells, perhaps setting the stage for conditions such as autism or schizophrenia, new research suggests. The origins of many neurodevelopment disorders remain mysterious. But the new study of postmortem brainContinue Reading

WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsyContinue Reading